Working antibiotics have given us a huge boost in quality of life over the last nine decades, but their importance and value is overlooked. Antibiotics play a crucial role in many more areas of life than most people imagine. This new report by ReAct and Dag Hammarskjöld Foundation looks at the state of global development...
Romanian EU Presidency aims to strengthen Europe’s One Health approach to fighting antimicrobial resistance
Antimicrobial resistance (AMR) is widely recognized as one of the 21st century’s greatest threats to health, welfare and food security. Worldwide, an estimated 700 000 people die each year from drug-resistant infections. In the European Union (EU) and European Economic Area (EEA) alone, 33 000 lives are claimed each year, and these numbers are rising.
Madam Therapeutics has been awarded a grant from the Netherlands Antibiotic Development Platform (NADP)
Madam Therapeutics announced that it is one of the four companies in the Netherlands that have been awarded a novel grant from the Netherlands Antibiotic Development Platform (NADP).
Together with the World Health Organization (WHO), The Netherlands will organise a global conference in April 2019 about the fight against antibiotic resistance.
Madam Therapeutics closes first financing round to develop novel antibiotics against drug resistant bacteria
Madam Therapeutics, a privately-held biotech company that is developing a novel class of antibiotics inspired by the defense mechanisms of the human body, today announced the closing of its first financing round of 1,1M EUR.
On the 22nd of May, alongside the annual World Health Assembly in Geneva the Global Antimicrobial Resistance and Development Hub (Global AMR R&D Hub) was launched.